Minimal inhibitory concentrations of lucknomycin, a new polyenic derivative, for Candida and Aspergillus spp.
AUTOR(ES)
Martínez-Quesada, J
RESUMO
The minimal inhibitory concentrations (MICs) of lucknomycin, a new polyenic derivative, were determined for 101 clinical isolates of Candida, 38 clinical or environmental strains of Aspergillus fumigatus, and 30 isolates of A. niger. The most susceptible species were Candida albicans and Candida tropicalis (mean MIC, 0.4 micrograms/ml). Aspergillus spp. were less susceptible, with mean MICs of 0.60 micrograms/ml for Aspergillus niger and 9.2 micrograms/ml for Aspergillus fumigatus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185117Documentos Relacionados
- A new coumarin derivative, 4-acetatecoumarin, with antifungal activity and association study against Aspergillus spp.
- Comparison of concentrations of rifampin and a new rifamycin derivative, DL 473, in canine bone.
- A 96-well epifluorescence assay for rapid assessment of compounds inhibitory to Candida spp.
- New Chromogenic Agar Medium for the Identification of Candida spp.
- Mode of action of a new nalidixic acid derivative, AB206.
